Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Home
Profiles
Research units
Equipment
Research output
Press/Media
Search by expertise, name or affiliation
Phase i dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
Yeul Hong Kim
, Hee Yeon Seo
, Yoon Tae Jeen
, Hoon Kyo Kim
*
, Byoung Yong Shim
, Jinmo Yang
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phase i dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Docetaxel
100%
Fixed-dose Combination
100%
Advanced Gastric Cancer
100%
Combination Chemotherapy
100%
Dose-escalation Study
100%
Dose Level
60%
Maximum Tolerated Dose
40%
Recommended Dose
40%
Neutropenia
20%
Safety Profile
20%
Overall Survival
20%
Dose-limiting Toxicity
20%
Median Time
20%
Survival Duration
20%
Time to Progression
20%
Twice Daily
20%
Advanced Gastric Carcinoma
20%
Locally Advanced
20%
Gastric Carcinoma
20%
Objective Response Rate
20%
Patient Cohort
20%
Dose Increase
20%
Pharmacology, Toxicology and Pharmaceutical Science
Docetaxel
100%
Chemotherapy
100%
Abdominal Cancer
100%
Stomach Carcinoma
40%
Maximum Tolerated Dose
40%
Disease
20%
Overall Survival
20%
Neutropenia
20%